MedTrace Logo

Single Rising Dose Study of BI 690517 in Healthy Volunteers

NCT02891148 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2024-09-20

No results posted yet for this study

Summary

To investigate safety, tolerability, pharmacokinetics and pharmacodynamics following single rising doses of BI 690517

Conditions

  • Healthy

Interventions

DRUG

BI 690517

Sponsors & Collaborators

Principal Investigators

  • Boehringer Ingelheim · Boehringer Ingelheim

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-29
Primary Completion
2016-12-12
Completion
2016-12-12

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02891148 on ClinicalTrials.gov